Learn / EXEL
NASDAQ: EXEL
Exelixis (EXEL) stock, explained like you're 5
Exelixis trades on the Nasdaq under the ticker EXEL. It is a large cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 14.8 billion dollars.
- Ticker
- EXEL
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Large cap, about 14.8 billion dollars
Is Exelixis a small, medium or large cap company?
Yes. Exelixis is a large cap stock. Its market cap, which is the total value of all its shares, is about 14.8 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Exelixis makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves EXEL stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Exelixis, Inc. (EXEL) Latest Stock News & Headlines (Yahoo Finance)
- Exelixis (NasdaqGS:EXEL) Stock Forecast & Analyst Predictions (Simply Wall Street)
- Exelixis, Inc. (EXEL) stock price, news, quote and history (Yahoo Finance Singapore)
- EXEL: Exelixis Inc Latest Stock Price, Analysis, News and Trading Ideas (Stocktwits)
- Is Exelixis Stock Engineered To Make You Money? (Trefis)
Follow EXEL in your daily brief
Each trading day at 5 PM ET we post what happened to Exelixis and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow EXEL
Questions about Exelixis stock
What does Exelixis do?
Exelixis trades on the Nasdaq under the ticker EXEL. It is a large cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 14.8 billion dollars.
What is the ticker symbol for Exelixis?
Exelixis trades under the ticker EXEL on the Nasdaq.
What is Exelixis's market cap?
Exelixis is a large cap stock with a market cap of about 14.8 billion dollars.
How does Exelixis make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves EXEL stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow EXEL stock every day?
Add EXEL to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.